CA
NZ
UK
AU
IND
US
RadNet, Inc. (NASDAQ:RDNT), a national leader in outpatient diagnostic imaging has reported its financial results for the first quarter of 2025, tempered by weather-related disruptions. At the same time, the company has raised its full-year financial guidance and made strategic moves to enhance its …
argenx SE [Euronext & Nasdaq: ARGX], a biotechnology firm focused on autoimmune diseases, announced its financial results for the first quarter of 2025, alongside updates on its expanding pipeline and regulatory progress. The company reported $790 million in global net product sales from VYVGART® …
Evotec SE (NASDAQ: EVO) has reported its financial results for Q1 2025, showcasing a solid start to the year despite challenges in the drug discovery market. The company achieved revenues of €200 million, a 4% decline compared to Q1 2024, aligning with their expectations. …
DexCom, Inc. (Nasdaq:DXCM)has reported its financial performance for the first quarter of 2025, with notable revenue growth, expanded product reach, and key regulatory milestones that signal continued momentum for the glucose monitoring technology leader.
BriaCell Therapeutics Corp., a clinical-stage biotechnology company, has presented new data from its ongoing pivotal Phase 3 trial of Bria-IMT™, an investigational immunotherapy for metastatic breast cancer (MBC). The study, titled BRIA-ABC (NCT06072612), explores how specific biomarkers might predict patient response to the Bria-IMT …
Basel Medical Group Ltd (Nasdaq: BMGL) has completed the acquisition of Bethesda Medical Pte. Ltd., a Singapore-based healthcare provider with three decades of experience in diagnostic imaging and outpatient medical services. The move strengthens Basel Medical’s footprint in Singapore and initiates its broader strategy …
The European Commission has approved the conversion of the conditional marketing approval (CMA) for FILSPARI into a standard marketing authorization (MA) for the treatment of primary IgA nephropathy (IgAN) in adults with a urine protein excretion of ≥1.0 g/day. This authorization applies across all …
Merck KGaA, Darmstadt, Germany (DAX:MRK), a leading science and technology company, has announced a definitive agreement to acquire SpringWorks Therapeutics, Inc. (Nasdaq:SWTX), a biopharmaceutical company focused on rare diseases and cancer. The deal, valued at approximately $3.9 billion, will see Merck KGaA purchase SpringWorks …
USANA Health Sciences, Inc. (NYSE:USNA) released stronger-than-expected quarterly earnings. The health and wellness company reported first-quarter earnings per share (EPS) of $0.73, surpassing analysts’ consensus forecast of $0.70. Revenue also outpaced expectations, coming in at $249.54 million against estimates of $243.08 million. However, year-over-year …
Intuitive Surgical, Inc. (Nasdaq:ISRG) has reported financial results for the first quarter ended March 31, 2025. the results are driven by the demand for robotic-assisted procedures and the adoption of its next-gen da Vinci 5 system powered growth across the board.
Please wait processing your request...